Orthofix M6-C Disc in First U.S. Patients Following PMA
Orthofix Medical announced first commercial U.S. implants of the M6-CÂ cervical disc following FDA Premarket Approval of the device. Apr 23, 2019
Regulatory Report: 42 Companies that Received their First Orthopedic-Related FDA 510(k) in 2018
Small companies around the world continue to seek access to the expansive U.S. market. In 2018, 42 companies received their first ever orthopedic-related FDA 510(k) or first FDA 510(k) in a new market segment. The companies and products we mention here are excerpted from chapters of the upcoming 2019 installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT. Apr 23, 2019
Shoulder Innovations Announces Long Term Data for Inset Glenoid
Shoulder Innovations' InSet Glenoid demonstrated long-term efficacy and safety in total shoulder replacement to reconstruct deficient, arthritic glenoid bone. Apr 18, 2019
Medicrea Gains Additional FDA Clearance for Surgical Planning Software
Medicrea enhanced the UNiD ASI (Adaptive Spine Intelligence) platform with addition of a device selection and surgical planning service, integrating a complete database of all Medicrea spine implants. Apr 18, 2019
Smith & Nephew Completes Osiris Acquisition
Smith & Nephew completed its acquisition of Osiris Therapeutics, which was announced in 1Q19. Apr 17, 2019
SpineCraft Introduces ASTRA SPINE SYSTEM Power Instrumentation
SpineCraft launched ASTRA Spine System Power Instrumentation to support complex spine, deformity, degenerative and MIS procedures. Apr 17, 2019
RepliCel Secures New Patents for Tendon Repair Technology
Replicel was granted patents in China, Europe and Russia addressing the use of fibroblast cell technology to treat chronically damaged tendons. Apr 16, 2019
Exactech Announces First Surgeries Using InterSep Bone Void Filler
Exactech announced the successful first procedure using InterSep calcium sulfate bone void filler. Apr 16, 2019
Bioretec Acquires BRI.Tech and Resorbable Metal Implant Technology
Bioretec acquired BRI.Tech, developer of a novel biocompatible and bioresorbable metal composition. Apr 16, 2019
In2Bones Launches ClearGuard LE for Endoscopic Soft Tissue Release
In2Bones commenced U.S. commercial launch of the ClearGuard LE Endoscopic Soft Tissue Release System to treat various foot conditions. Apr 16, 2019
